Boccon-Gibod, Clémentine <br/><br/>
Carfilzomib, venetoclax and dexamethasone for relapsed/refractory multiple myeloma.  [electronic resource] 

 -  British journal of haematology  05 2020 
 - e73-e76 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>1365-2141 
<br/><br/><label>Standard No.: </label>10.1111/bjh.16483  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Bridged Bicyclo Compounds, Heterocyclic--pharmacology<br/>Dexamethasone--pharmacology<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--drug therapy<br/>Neoplasm Recurrence, Local<br/>Oligopeptides--pharmacology<br/>Sulfonamides--pharmacology